Hsu C.-R.Chen Y.-Y.MING YAOYI-HSUAN WEIYI-TING HSIEHSHU-LANG LIAO2021-09-042021-09-0420210950-222Xhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85091685425&doi=10.1038%2fs41433-020-01198-y&partnerID=40&md5=a9f1f11102e00d3fd10a2c58d6d8905ahttps://scholars.lib.ntu.edu.tw/handle/123456789/581611Purpose: To investigate the clinical features, prognostic outcomes of patients with orbital and ocular adnexal lymphoma (OALs) in Taiwanese cohort. Methods: Total 112 patients with OALs were retrospectively reviewed. Demographic information such as age, g[SDGs]SDG3cyclophosphamide; cyclophosphamide plus doxorubicin plus prednisolone plus rituximab plus vincristine; doxorubicin; doxycycline; prednisone; rituximab; vincristine; adult; aged; Article; B cell lymphoma; cancer combination chemotherapy; cancer grading; cajournal article10.1038/s41433-020-01198-y329945472-s2.0-85091685425